https://www.marketscreener.com/quote/stock/PROQR-THERAPEUTICS-N-V-17916812/news/ProQR-to-Present-Findings-from-Phase-1-2-Interim-Analysis-of-QR-421a-for-Usher-Syndrome-30252719/?utm_source=telegram&utm_medium=social&utm_campaign=share